Home » Topics » BioWorld Science

BioWorld Science
RSS

Low-estrogen oral contraceptives have low stroke risk

July 5, 1996

Oral contraceptive displays cardioprotective effects

July 5, 1996

Ciba-Geigy introduces Noven's Vivelle in Canada

July 5, 1996

Memory impairment common side effect of GnRH agonist therapy

July 5, 1996

Ethical files PLA for estrogen/levonorgestrel patch in U.K.

July 5, 1996

U.S. clinical trials begin for Ethical Holdings' estradiol patch

July 5, 1996

Alteon describes new glucose-lowering agent

July 5, 1996

Nippon Chemiphar reports oral hypoglycemic agents for diabetes

July 5, 1996

Sankyo discloses sulfonamide derivatives for diabetes

July 5, 1996

Good phase I results reported for Campylobacter vaccine

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...